Literature DB >> 27075901

Temporal Trends in the Use of Investigations After Stroke or Transient Ischemic Attack.

Vivian T Ng1, Ahmed M Bayoumi, Jiming Fang, Kirsteen R Burton, Melissa Stamplecoski, Jodi D Edwards, Moira K Kapral.   

Abstract

BACKGROUND: Guidelines recommend that patients with stroke or transient ischemic attack (TIA) undergo neuroimaging and cardiac investigations to determine etiology and guide treatment. It is not known how the use of these investigations has changed over time and whether there have been associated changes in management.
OBJECTIVES: To evaluate temporal trends in the use of brain and vascular imaging, echocardiography, and antithrombotic and surgical therapy after stroke or TIA. RESEARCH
DESIGN: We analyzed 42,738 patients with stroke or TIA presenting to any of the 11 regional stroke centers in Ontario, Canada between 2003 and 2012 using the Ontario Stroke Registry database. The study period was divided into 1-year intervals and we used the Cochran-Armitage test to determine trends over time.
RESULTS: Between 2003/2004 and 2011/2012, the proportion of patients undergoing brain imaging increased from 96% to 99%, as did the proportion receiving ≥3 brain scans (21%-39%), magnetic resonance imaging (13%-50%), vascular imaging (62%-88%), or echocardiography (52%-70%) (P<0.0001 for all comparisons). There was an increase in the proportion receiving any antithrombotic therapy (83%-91%, P<0.0001) but no change in use of anticoagulation (25% overall and 68% in subgroup with atrial fibrillation) or carotid revascularization (1.4%-1.5%, P=0.49).
CONCLUSIONS: The use of investigations after stroke has increased over time without concomitant changes in medical or surgical management. Although initial neurovascular imaging is in accordance with practice guidelines, the use of multiple imaging procedures and routine echocardiography are of uncertain clinical effectiveness.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27075901     DOI: 10.1097/MLR.0000000000000499

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  6 in total

1.  Updated Trends, Disparities, and Clinical Impact of Neuroimaging Utilization in Ischemic Stroke in the Medicare Population: 2012 to 2019.

Authors:  Jason J Wang; Casey E Pelzl; Artem Boltyenkov; Jeffrey M Katz; Jennifer Hemingway; Eric W Christensen; Elizabeth Rula; Pina C Sanelli
Journal:  J Am Coll Radiol       Date:  2022-04-25       Impact factor: 6.240

2.  Value of routine echocardiography in the management of stroke.

Authors:  Mike Fralick; Nicola Goldberg; Sagar Rohailla; Yishan Guo; Matthew J Burke; Lauren Lapointe-Shaw; Janice L Kwan; Adina S Weinerman; Shail Rawal; Terence Tang; Fahad Razak; Amol A Verma
Journal:  CMAJ       Date:  2019-08-06       Impact factor: 8.262

3.  Stroke Imaging: Quantity, But is There Quality?

Authors:  Deborah A Levine; James F Burke
Journal:  Med Care       Date:  2016-05       Impact factor: 2.983

4.  Clinical Utility and Cost of Inpatient Transthoracic Echocardiography Following Acute Ischemic Stroke.

Authors:  Margaret Moores; Vignan Yogendrakumar; Olena Bereznyakova; Walid Alesefir; Kednapa Thavorn; Hailey Pettem; Grant Stotts; Dar Dowlatshahi; Michel Shamy
Journal:  Neurohospitalist       Date:  2020-07-31

Review 5.  Cardiac Imaging After Ischemic Stroke or Transient Ischemic Attack.

Authors:  S Camen; K G Haeusler; R B Schnabel
Journal:  Curr Neurol Neurosci Rep       Date:  2020-06-30       Impact factor: 5.081

Review 6.  Expert opinion paper on cardiac imaging after ischemic stroke.

Authors:  Renate B Schnabel; Stephan Camen; Fabian Knebel; Andreas Hagendorff; Udo Bavendiek; Michael Böhm; Wolfram Doehner; Matthias Endres; Klaus Gröschel; Andreas Goette; Hagen B Huttner; Christoph Jensen; Paulus Kirchhof; Grigorios Korosoglou; Ulrich Laufs; Jan Liman; Caroline Morbach; Darius Günther Nabavi; Tobias Neumann-Haefelin; Waltraud Pfeilschifter; Sven Poli; Timolaos Rizos; Andreas Rolf; Joachim Röther; Wolf Rüdiger Schäbitz; Thorsten Steiner; Götz Thomalla; Rolf Wachter; Karl Georg Haeusler
Journal:  Clin Res Cardiol       Date:  2021-06-18       Impact factor: 5.460

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.